ReviewJournal of personalized medicine2020

Biomarker Development for Metastatic Renal Cell Carcinoma: Omics, Antigens, T-cells, and Beyond.

Benjamin Miron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.